Viewing Study NCT02588859


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-01-20 @ 4:52 PM
Study NCT ID: NCT02588859
Status: COMPLETED
Last Update Posted: 2017-12-19
First Post: 2015-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T2DM, Diabetes View